FindTrial
Sign In

Clinical phenotype of fibrous dysplasia and the efficacy and safety of bisphosphonate intervention: a retrospective study based on medical records

Clinical phenotype of fibrous dysplasia and the efficacy and safety of bisphosphonate intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032676
Enrollment
Unknown
Registered
2020-05-06
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrous dysplasia of bone

Interventions

case series:N/A

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of fibrous dysplasia in Chinese Han population. 2. Patients who fully understand the purpose and process of the study and are willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with other diseases affecting bone metabolism; 2. Patients who take drugs that affect bone metabolism (except vitamin D and calcium tablets) for a long time.

Design outcomes

Primary

MeasureTime frame
serum bone metabolism marker;—

Secondary

MeasureTime frame
Skeletal pain symptoms;—

Countries

China

Contacts

Public ContactShanshan Li

Shanghai Sixth People's Hospital

lissane0508@126.com+86 15216615650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026